General Voorkennis Nieuws Regulated Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion EN NL FR februari 16, 2026
General Voorkennis Nieuws Regulated Oxurion announces the temporary suspension of the financing programme dedicated to investments in digital assets and crypto-assets EN NL FR januari 19, 2026
General Voorkennis Nieuws Regulated Axiodis CRO, the French subsidiary of the Oxurion Group, announces a dual AI-driven strategic initiative to transform clinical trials EN NL FR september 16, 2025
General Voorkennis Nieuws Regulated Oxurion completes the acquisition of Axiodis CRO and accelerates the structuring of its European clinical data platform EN NL FR augustus 4, 2025
General Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC EN NL april 2, 2025
General Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL januari 20, 2025
General Nieuws Regulated Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC EN NL januari 14, 2025
General Nieuws Regulated Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas EN NL januari 13, 2025
General Regulated Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC EN NL januari 13, 2025
General Nieuws Oxurion NV: Key developments and timeline for current the potential acquisition EN FR NL oktober 29, 2024
General Nieuws Important Advances in Oxurion’s R&D Program on Geographic Atrophy secondary to AMD EN NL FR mei 6, 2024
General Nieuws Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program : Eleventh tranche fully issued and paid-up EN FR april 10, 2024
General Nieuws OXURION announces its presence at the Paris SmallCap event on March 28, 2024. EN FR maart 25, 2024
General Nieuws Oxurion Receives EUR 300,000 in the framework of the Atlas Funding Program Tenth tranche fully issued and paid-up EN FR maart 5, 2024
General Nieuws Oxurion Receives EUR 850,000 in the framework of the Atlas Funding Program Eight and ninth tranches fully issued and paid-up EN FR februari 14, 2024
General Nieuws Oxurion Announces New Strategic Orientation to De-risk and Diversify EN NL FR januari 22, 2024
General Nieuws Regulated Oxurion Avoids Bankruptcy, Announces Board and Management Changes and Enters into Binding Letter of Intent with its Main Creditor Atlas EN NL december 28, 2023
